How Knowledge Transfer Partnerships can benefit the Medicines Manufacturing Sector: watch the recording
Find out how a KTP could be an opportunity to grow your business through the recording of our event from 16th September.
On Monday 16th September, delegates from the Medicines Manufacturing sector joined KTN representatives in an interactive webinar session aimed at highlighting the value and opportunities in Knowledge Transfer Partnerships (KTPs) to this sector.
The webinar was held to demonstrate the value of KTPs to the medicines manufacturing sector and to showcase how delegates could benefit from KTPs themselves. You can watch back the recording of the recording here.
KTPs aim to help businesses improve their competitiveness and productivity through the better use of knowledge, technology and skills held within the UK knowledge base.¬† The Knowledge Transfer Network delivers the KTP programme for Innovate UK, funded through¬†UK Research and Innovation¬†as part of the government‚Äôs¬†Industrial Strategy. KTPs create a partnership between a university and a talented graduate/post-graduate (a KTP Associate who acts as a Project Manager), leading to transformational change to organisations and embedding knowledge.
KTPs can benefit companies of all sizes from any sector and they last for between 12 and 36 months. You can find further information on KTPs here¬†- ¬†applications for funding¬†are open all year round.
The webinar allowed delegates to view interviews as part of a case study of a current KTP in action. This involved interviews with Margaret Courtney from Lamellar Biotechnologies (who are currently part-way through their second KTP, Marco Rotondi (a KTP Associate who participated on a KTP project with Sartorius), and Dr. Qasim Rafiq from University College London (he acted as Marco‚Äôs academic supervisor on the project).
Margaret Courtney said, ‚ÄúWe are a third of the way through the current KTP and we‚Äôve got some promising data on some processing techniques that look like they should improvements in terms of productivity.¬† We thoroughly recommend going ahead for KTPs – they’re an invaluable way, particularly for smaller organizations, to access and technologies.¬† We have seen invaluable support from the KTP office‚Äù.
Dr. Qasim Rafiq¬†also said, ‚ÄúGetting involved in a KTP is an excellent mechanism for Industrial Academic Collaborations‚Äù, while Marco Rotondi added that a KTP was ‚Äúa great idea to applying research to a commercial environment and use research to make a final product‚Ä¶this was exciting for me as an engineer‚Äù.
The attendees were able to post questions throughout the webinar, and you can watch back a recording of the webinar here.
The KTN is here to support the Medicines Manufacturing Challenge Community. For more information on the community please click here.
If you have any questions about the KTP programme, please contact: